Issue 18 – Manulife Beats to its Own Drum

Earnings season can be quite a hectic time for many companies. Speculation, headlines and surprising results can drastically move stock prices. This earnings season, we were particularly interested in Manulife’s (TSX: MFC) results as there has been a lot of talk lately regarding their long-term care (LTC) business and the new life insurance capital adequacy test or LICAT. Furthermore, Manulife’s stock price has been under pressure since January when GE reported losses of US$6.2 billion on its LTC business.

Continue Reading in PDF